change control – Page 35 – Pharma.Tips

Change control documentation gaps during deviation investigation – risk-based change impact assessment

Addressing Change Control Documentation Gaps in Deviation Investigations: A Risk-Based Playbook Pharmaceutical manufacturing involves numerous complexities, and deviations can lead to significant operational setbacks. A critical aspect of robust deviation…

Raw material change implemented without assessment during deviation investigation – risk-based change impact assessment

Managing Raw Material Changes Without Prior Assessment During Deviations: An Effective Playbook The pharmaceutical industry faces a multitude of challenges regarding raw material management, particularly when material changes occur without…

Unapproved material substitution during post-approval change review – risk-based change impact assessment

Managing Risks of Unapproved Material Substitution in Post-Approval Changes Unapproved material substitutions during post-approval change reviews pose significant risks in pharmaceutical manufacturing. They can lead to quality deviations, regulatory non-compliance,…

Supplier change not evaluated during deviation investigation – CAPA to prevent repeat failures

Effective Strategies for Evaluating Supplier Changes During Deviation Investigations Changes in suppliers of raw materials can significantly impact the quality and safety of pharmaceutical products. When these changes are not…

Specification change not communicated during routine operations – CAPA to prevent repeat failures

Addressing Uncommunicated Specification Changes during Routine Operations: A Comprehensive CAPA Playbook Specification changes that go uncommunicated during manufacturing operations can lead to significant quality issues, regulatory concerns, and increased operational…

Change impact underestimated during routine operations – regulatory expectations for material changes

Understanding Regulatory Expectations for Material Changes in Routine Operations In the fast-paced environment of pharmaceutical manufacturing, routine operations often pave the way for product quality and compliance. However, the impact…

Uncontrolled Material Changes Causing Deviations? Raw Material Change Control Strategy

Addressing Uncontrolled Changes in Raw Material: A Comprehensive Change Control Strategy In the pharmaceutical manufacturing environment, uncontrolled changes to raw materials can lead to significant deviations that jeopardize product quality…

Weak QMS Causing Repeat Deviations? QMS Design Solutions

Is Your Quality Management System Contributing to Repeat Deviations? Discover Solutions Weaknesses within a Quality Management System (QMS) can lead to repeated deviations in pharmaceutical manufacturing and quality control processes.…

QA Bottlenecks Slowing Release? Systems and Workflow Solutions

Addressing QA Bottlenecks Affecting Batch Release: Effective Systems and Workflow Solutions In the realm of pharmaceutical manufacturing, quality assurance (QA) plays a critical role in ensuring the integrity and safety…

Change Control Failures Triggering Deviations? Root Causes and Fixes

Understanding and Resolving Change Control Failures in Pharmaceutical Manufacturing Change control failures in pharmaceutical manufacturing are critical events that can disrupt processes and lead to significant compliance issues. These failures…

API Quality Variability Problems? Supplier, Testing, and Control Strategy Solutions

Addressing API Quality Variability: Solutions for Supplier, Testing, and Control Challenges The production of active pharmaceutical ingredients (APIs) is a critical aspect of pharmaceutical manufacturing, yet quality variability is an…

Raw Material Variability and Supplier Risk? Control Strategy Solutions for APIs and Excipients

Tackling Variability in Raw Materials and Supplier Risks: Control Strategies for APIs and Excipients Variability in raw materials and potential risks associated with suppliers have become pressing challenges within pharmaceutical…